Dostinex (Cabergoline)

cabergoline 500 microgram tablet, 8 · ORAL · PBS code 8114C

RESTRICTED

What it costs

AU$9.1 PBS-determined price per 8 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 1997-02-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Pathological hyperprolactinaemia

Patient must be one in whom surgery is not indicated.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Pathological hyperprolactinaemia

Patient must have had surgery for this condition with incomplete resolution.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Pathological hyperprolactinaemia

Patient must be one in whom radiotherapy is not indicated.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Pathological hyperprolactinaemia

Patient must have had radiotherapy for this condition with incomplete resolution.

Sponsor: Pfizer Australia Pty Ltd ABN 50 008 422 348

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.